NCT02630654 - Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs | Biotech Hunter

Enrollment

404

Participants

Timeline

Start Date

March 24, 2014

Primary Completion Date

November 9, 2021

Study Completion Date

November 9, 2021

Conditions

Gastroenteropancreatic Neuroendocrine Tumors

Interventions

OTHER

This is a non-interventional study. Patients will be treated with any intervention deemed appropriate by the patient's physician.

Trial Locations (25)

Aarhus

Copenhagen

Odense

North Estonia Medical Center, Tallinn

Helsinki

Oulu

Tampere

Pauls Stradins Clinical University Hospital, Riga

Riga East University Hospital, Riga

The Hospital of Lithuanian Health Science, Kaunas

Klaipėda University Hospital, Klaipėda

National Cancer Institute, Vilnius

Vilnius University Hospital, Vilnius

Bergen

Oslo

Stavanger

Trondheim

Gothenburg

Jönköping

Lund

Örebro

Karolinska Universitetssjukhuset Bröst - och Endokrinkirurgiska kliniken, Stockholm

Södersjukhuset, Stockholm

Umeå

Uppsala